IDEXX LABORATORIES INC (IDXX) Cash flow
Market cap
$45.8B
P/E ratio
| 2010/12 | 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Depreciation & amortization | 46 | 48 | 52 | 55 | 59 | 69 | 78 | 83 | 83 | 88 | 96 | 105 | 112 | 115 | 130 |
| Stock-based compensation | 13 | 15 | 16 | 17 | 18 | 20 | 20 | 24 | 25 | 39 | 31 | 38 | 50 | 60 | 60 |
| Cash from operations | 179 | 221 | 230 | 246 | 236 | 216 | 335 | 373 | 400 | 459 | 648 | 756 | 543 | 907 | 929 |
| Capital expenditures | -39 | -52 | -65 | -78 | -61 | -83 | -65 | -74 | -116 | -155 | -107 | -120 | -149 | -134 | -121 |
| Cash from investing | -43 | -97 | -66 | -86 | -80 | -308 | -91 | -139 | 139 | -206 | -109 | -293 | -195 | -125 | -207 |
| Repurchases of common stock | 143 | 256 | 132 | 368 | 618 | 402 | 304 | 283 | 369 | 302 | 183 | 747 | 820 | 72 | 837 |
| Cash from financing | -87 | -98 | -125 | -102 | -103 | -96 | -218 | -208 | -598 | -286 | -248 | -697 | -371 | -442 | -878 |
| Free cash flow | |||||||||||||||
| FCF margin (%) | - |